SHARE-BASED COMPENSATION (Tables)

12 Months Ended

Dec. 31, 2012

The weighted average assumptions for the years ended December 31, 2012, 2011, and 2010 are noted in the following table:


	2012			2011			2010
Expected life (years)		6.2			6.2			6.1
Expected volatility		41.9	%		40.0	%		43.3	%
Expected dividend yield		1.01	%		1.04	%		0.19	%
Risk-free interest rate		2.11	%		3.36	%		3.75	%
Weighted-average fair value per option	$	19.91		$	20.83		$	16.73

Summary of Stock Options and Stock-Settled SARS Activity

A summary of stock options and stock-settled SARS activity for the year ended December 31, 2012 is presented below:


Options and Stock-Settled SARS Activity:⁽¹⁾	Number of Units			Weighted Average Exercise Price Per Unit		Weighted Average Remaining Contractual Life (Years)		Aggregate Intrinsic Value
Outstanding at January 1, 2012		3,305,399		$	42.71
Granted		470,809			50.33
Exercised		(1,033,941	)		36.81
Forfeited		(69,537	)		47.47

Outstanding at December 31, 2012		2,672,730		$	46.22		5.7	$	60.4

Exercisable at December 31, 2012		1,849,254		$	45.22		4.5	$	43.7

(1)	Options and stock-settled SARS in the table above include awards to all recipients, including those who are part of discontinued businesses.

Summary of Non-Vested Stock and Non-Vested Stock Units

A summary of non-vested stock and non-vested stock units for the year ended December 31, 2012 is presented below:


Non-vested Stock and Stock Units:⁽¹⁾	Number of Units			Weighted Average Grant Date Fair Value Per Unit
Nonvested at January 1, 2012		180,930		$	40.40
Granted		77,822			50.79
Vested		(45,463	)		18.67
Forfeited		(9,432	)		46.84

Nonvested at December 31, 2012		203,857		$	47.75

(1)	Non-vested stock and stock units in the table above include awards to all recipients, including those who are part of discontinued businesses.

- Definition

Tabular disclosure of components of a stock option or other award plan under which equity-based compensation is awarded to employees, typically comprised of the amount of unearned compensation (deferred compensation cost), compensation expense, and changes in the quantity and fair value of the shares (or other type of equity) granted, exercised, forfeited, and issued and outstanding pertaining to that plan. Disclosure may also include nature and general terms of such arrangements that existed during the period and potential effects of those arrangements on shareholders, effect of compensation cost arising from equity-based payment arrangements on the income statement, method of estimating the fair value of the goods or services received, or the fair value of the equity instruments granted, during the period, cash flow effects resulting from equity-based payment arrangements and, for registrants that accelerate vesting of out of the money share options, reasons for the decision to accelerate.

+ References+ Details